Table 1:
Summary of recent research studies on cancer bioprinting
| Bioink Composition | Viability | Cancer Type | Method | Ref |
|---|---|---|---|---|
| Ovarian Cancer Cells / Fibroblasts + Matrigel | >95% | Ovarian | Extrusion | [10] |
| Endothelial Cells + Glioma Stem Cells + Collagen/Laminin | N/A | Brain | Extrusion | [11] |
| β-Tricalciumphosphate | N/A | Oral | Extrusion | [12] |
| U118 glioma + Pluripotent Stem Cell Derived Neural Organoid | N/A | Brain | Extrusion | [13] |
| MDA-MB-231/IMR-90 MCTS | High | Breast | Extrusion | [14] |
| HeLa + Gelatin/Alginate/Fibrinogen | >95% | Cervical | Extrusion | [15] |
| HeLa + Gelatin / Alginate / Fibrinogen | >90% | Cervical | Extrusion | [16] |
| Human Glioma Stem Cells+Gelatin/Alginate/Fibrinogen | 87% | Brain | Extrusion | [17] |
| GAM + GBM+Gelatin Methacryloyl /Gelatin | High | Brain | Extrusion | [18] |
| Breast Adenocarcinoma + Mouse Macrophage+ Sodium alginate | >90% | Breast | Coaxial Extrusion | [19] |
| GSC123+U118+ Sodium alginate | >90% | Brain | Coaxial Extrusion | [20] |
| GSC23 +HMSCs+Sodium Alginate/Gelatin | >90% | Brain | Coaxial Extrusion | [21] |
| Mesenchymal Stem Cells + Gelatin Methacrylate | 30% - 50% | Breast | Stereolithography | [22] |
| HeLa + 10 T1/2+PEGDA | N/A | Cervical | Stereolithography | [23] |
| hBMSCs+ MDA-MB-231/MCF-7 | 53% - 80% | Breast | Stereolithography | [24] |
| MCF-7+PEG | >90% | Breast | Inkjet | [26] |